The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Open accessAbstract
There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and novel modes of action, to widen the scope of treatment and to overcome emerging drug resistance. Here we describe the discovery of DDD107498, a compound with a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite, with good pharmacokinetic properties and an acceptable safety profile. DDD107498 demonstrates potential to address a variety of clinical needs, including single-dose treatment, transmission blocking and chemoprotection. DDD107498 was developed from a screening programme against blood-stage malaria parasites; its molecular target has been identified as translation elongation factor 2 (eEF2), which is responsible for the GTP-dependent translocation of the ribosome along messenger RNA, and is essential for protein synthesis. This discovery of eEF2 as a viable antimalarial drug target opens up new possibilities for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
A proteomic view of the Plasmodium falciparum life cycle
Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., Moch, J. K., Muster, N., Sacci, J. B., Tabb, D. L., et al. (2002) · Nature · doi:10.1038/nature01107 · Cited by 1,308
Self-citationSpiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Self-citationBousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700139 · Cited by 709
Self-citationA Research Agenda to Underpin Malaria Eradication
Alonso, P. L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O. K., Greenwood, B., Hall, B. F., Levine, M. M., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000406 · Cited by 667
Self-citationAnalysis of Plasmodium falciparum diversity in natural infections by deep sequencing
Manske, M., Miotto, O., Campino, S., Auburn, S., Almagro-Garcia, J., Maslen, G., O’Brien, J., Djimde, A., Doumbo, O., Zongo, I., et al. (2012) · Nature · doi:10.1038/nature11174 · Cited by 486
Self-citationMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
Miotto, O., Almagro-Garcia, J., Manske, M., MacInnis, B., Campino, S., Rockett, K. A., Amaratunga, C., Lim, P., Suon, S., Sreng, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2624 · Cited by 462
Self-citationHigh efficiency transfection of Plasmodium berghei facilitates novel selection procedures
Janse, C. J., Franke-Fayard, B., Mair, G. R., Ramesar, J., Thiel, C., Engelmann, S., Matuschewski, K., Gemert, G. J. V., Sauerwein, R. W., & Waters, A. P. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2005.09.007 · Cited by 437
Self-citationTargeting Plasmodium PI(4)K to eliminate malaria
McNamara, C. W., Lee, M. C. S., Lim, C. S., Lim, S. H., Roland, J., Nagle, A., Simon, O., Yeung, B. K. S., Chatterjee, A. K., McCormack, S. L., et al. (2013) · Nature · doi:10.1038/nature12782 · Cited by 431
Self-citationDelves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 377
Self-citationCharman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C. K., Chollet, J., Craft, J. C., Creek, D. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015762108 · Cited by 373
Self-citationImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Self-citationAdjalley, S. H., Johnston, G. L., Li, T., Eastman, R. T., Ekland, E. H., Eappen, A. G., Richman, A., Sim, B. K. L., Lee, M. C. S., Hoffman, S. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112037108 · Cited by 309
Self-citationA Research Agenda for Malaria Eradication: Drugs
The malERA Consultative Group on Drugs (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000402 · Cited by 288
Designing the next generation of medicines for malaria control and eradication
Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C., & Wells, T. N. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-187 · Cited by 282
Nkrumah, L. J., Muhle, R. A., Moura, P. A., Ghosh, P., Hatfull, G. F., Jacobs, W. R., & Fidock, D. A. (2006) · Nature Methods · doi:10.1038/nmeth904 · Cited by 245
Self-citationSanz, L. M., Crespo, B., De-Cózar, C., Ding, X. C., Llergo, J. L., Burrows, J. N., García-Bustos, J. F., & Gamo, F.-J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030949 · Cited by 225
Self-citationDelves, M. J., Ruecker, A., Straschil, U., Lelièvre, J., Marques, S., López-Barragán, M. J., Herreros, E., & Sinden, R. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-13 · Cited by 200
Self-citationElongation Factor 2 as a Novel Target for Selective Inhibition of Fungal Protein Synthesis
Justice, M. C., Hsu, M.-J., Tse, B., Ku, T., Balkovec, J., Schmatz, D., & Nielsen, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3148 · Cited by 189
Jørgensen, R., Ortiz, P. A., Carr-Schmid, A., Nissen, P., Kinzy, T. G., & Andersen, G. R. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb923 · Cited by 164
Angulo-Barturen, I., Jiménez-Díaz, M. B., Mulet, T., Rullas, J., Herreros, E., Ferrer, S., Jiménez, E., Mendoza, A., Regadera, J., Rosenthal, P. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002252 · Cited by 163
Self-citationDeterminants of In Vitro Drug Susceptibility Testing of Plasmodium vivax
Russell, B., Chalfein, F., Prasetyorini, B., Kenangalem, E., Piera, K. A., Suwanarusk, R., Brockman, A., Prayoga, P., Sugiarto, P., Cheng, Q., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01334-07 · Cited by 139
Self-citationKaryana, M., Burdarm, L., Yeung, S., Kenangalem, E., Wariker, N., Maristela, R., Umana, K. G., Vemuri, R., Okoseray, M. J., Penttinen, P. M., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-148 · Cited by 135
Self-citationThe life and death of translation elongation factor 2
Merrill, A. R., Jørgensen, R., & Andersen, G. R. (2005) · Biochemical Society Transactions · doi:10.1042/bst20060001 · Cited by 112
Transmission-blocking interventions eliminate malaria from laboratory populations
Blagborough, A. M., Churcher, T. S., Upton, L. M., Ghani, A. C., Gething, P. W., & Sinden, R. E. (2013) · Nature Communications · doi:10.1038/ncomms2840 · Cited by 109
Self-citationThe life and death of translation elongation factor 2
Jørgensen, R., Merrill, A. R., & Andersen, G. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340001 · Cited by 105
Jiménez-Dı́az, M. B., Mulet, T., Gómez, V., Viera, S., Alvarez, A., Garuti, H., Vázquez, Y., Fernández, A. F., Ibáñez, J., Jiménez, M., et al. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20647 · Cited by 85
Self-citationA framework for assessing the risk of resistance for anti-malarials in development
Ding, X. C., Ubben, D., & Wells, T. N. C. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-292 · Cited by 78
Translation Elongation Factor 2 Is Part of the Target for a New Family of Antifungals
Capa, L., Mendoza-Losana, A., Lavandera, J. L., Heras, F. G. D. L., & Garcia-Bustos, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2694 · Cited by 75
Flannery, E. L., Fidock, D. A., & Winzeler, E. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400325j · Cited by 71
Self-citationA high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines
Delves, M. J., Ramakrishnan, C., Blagborough, A. M., et al. (2012) · International Journal for Parasitology · doi:10.1016/j.ijpara.2012.08.009 · Cited by 64
Self-citationRibosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid
Cox, G., Thompson, G. S., Jenkins, H. T., Peske, F., Savelsbergh, A., Rodnina, M. V., Wintermeyer, W., Homans, S. W., Edwards, T. A., & O’Neill, A. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117275109 · Cited by 63
Shastry, M., NIELSEN, J. B. K., Ku, T., Hsu, M., Liberator, P., Anderson, J. W., Schmatz, D. M., & Justice, M. C. (2001) · Microbiology · doi:10.1099/00221287-147-2-383 · Cited by 54
Upton, L. M., Brock, P. M., Churcher, T. S., Ghani, A. C., Gething, P. W., Delves, M. J., Sala, K., Leroy, D., Sinden, R. E., & Blagborough, A. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03942-14 · Cited by 26
Self-citation
Cited by
Cowman, A. F., Healer, J., Marapana, D., & Marsh, K. (2016) · Cell · doi:10.1016/j.cell.2016.07.055 · Cited by 890
Phillips, M. A., Burrows, J. N., Manyando, C., van Huijsduijnen, R. H., Van Voorhis, W. C., & Wells, T. N. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.50 · Cited by 649
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Blasco, B., Leroy, D., & Fidock, D. A. (2017) · Nature Medicine · doi:10.1038/nm.4381 · Cited by 576
Self-citationScreening out irrelevant cell-based models of disease
Horvath, P., Aulner, N., Bickle, M., Davies, A. M., Nery, E. D., Ebner, D., Montoya, M. C., Östling, P., Pietiäinen, V., Price, L. S., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.175 · Cited by 525
Lin, X., Chai, G., Wu, Y., Li, J., Chen, F., Liu, J., Luo, G., Tauler, J., Du, J., Lin, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09865-9 · Cited by 510
Retracted
Metadata
- Authors
- Baragaña, B., Hallyburton, I., Lee, M. C. S., Norcross, N. R., Grimaldi, R., Otto, T. D., Proto, W. R., Blagborough, A. M., Meister, S., Wirjanata, G., Ruecker, A., Upton, L. M., Abraham, T. S., Almeida, M. J., Pradhan, A., Porzelle, A., Martínez, M. S., Bolscher, J. M., Woodland, A., Luksch, T., Norval, S., Zuccotto, F., Thomas, J., Simeons, F., Stojanovski, L., Osuna-Cabello, M., Brock, P. M., Churcher, T. S., Sala, K. A., Zakutansky, S. E., Jiménez-Díaz, M. B., Sanz, L. M., Riley, J., Basak, R., Campbell, M., Avery, V. M., Sauerwein, R. W., Dechering, K. J., Noviyanti, R., Campo, B., Frearson, J. A., Angulo-Barturen, I., Ferrer-Bazaga, S., Gamo, F. J., Wyatt, P. G., Leroy, D., Siegl, P., Delves, M. J., Kyle, D. E., Wittlin, S., Marfurt, J., Price, R. N., Sinden, R. E., Winzeler, E. A., Charman, S. A., Bebrevska, L., Gray, D. W., Campbell, S., Fairlamb, A. H., Willis, P. A., Rayner, J. C., Fidock, D. A., Read, K. D., & Gilbert, I. H.
- Venue
- Nature
- Published
- 2015-06-17
- Volume
- 522
- Issue
- 7556
- Pages
- 315-320
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1935711444
- Cited by
- 454
- References
- 35
- FWCI
- 48.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.